Global Antibody drug Conjugates Market Research Report 2023(Status and Outlook)

Global Antibody drug Conjugates Market Research Report 2023(Status and Outlook)



Report Overview

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

The Global Antibody drug Conjugates Market Size was estimated at USD 2734.4 million in 2022 and is projected to reach USD 3771.28 million by 2029, exhibiting a CAGR of 4.70% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Antibody drug Conjugates market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antibody drug Conjugates Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antibody drug Conjugates market in any manner.

Global Antibody drug Conjugates Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

ImmunoGen

Seattle Genetics

Roche

Takeda

Market Segmentation (by Type)

Adcetris

Kadcyla

Market Segmentation (by Application)

Cooling MRIs

Cooling CTs

Cooling Linear Accelerators

Other Medical use

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Antibody drug Conjugates Market

Overview of the regional outlook of the Antibody drug Conjugates Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antibody drug Conjugates
1.2 Key Market Segments
1.2.1 Antibody drug Conjugates Segment by Type
1.2.2 Antibody drug Conjugates Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antibody drug Conjugates Market Overview
2.1 Global Market Overview
2.1.1 Global Antibody drug Conjugates Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Antibody drug Conjugates Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antibody drug Conjugates Market Competitive Landscape
3.1 Global Antibody drug Conjugates Sales by Manufacturers (2018-2023)
3.2 Global Antibody drug Conjugates Revenue Market Share by Manufacturers (2018-2023)
3.3 Antibody drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antibody drug Conjugates Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Antibody drug Conjugates Sales Sites, Area Served, Product Type
3.6 Antibody drug Conjugates Market Competitive Situation and Trends
3.6.1 Antibody drug Conjugates Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antibody drug Conjugates Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antibody drug Conjugates Industry Chain Analysis
4.1 Antibody drug Conjugates Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antibody drug Conjugates Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antibody drug Conjugates Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antibody drug Conjugates Sales Market Share by Type (2018-2023)
6.3 Global Antibody drug Conjugates Market Size Market Share by Type (2018-2023)
6.4 Global Antibody drug Conjugates Price by Type (2018-2023)
7 Antibody drug Conjugates Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antibody drug Conjugates Market Sales by Application (2018-2023)
7.3 Global Antibody drug Conjugates Market Size (M USD) by Application (2018-2023)
7.4 Global Antibody drug Conjugates Sales Growth Rate by Application (2018-2023)
8 Antibody drug Conjugates Market Segmentation by Region
8.1 Global Antibody drug Conjugates Sales by Region
8.1.1 Global Antibody drug Conjugates Sales by Region
8.1.2 Global Antibody drug Conjugates Sales Market Share by Region
8.2 North America
8.2.1 North America Antibody drug Conjugates Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antibody drug Conjugates Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antibody drug Conjugates Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antibody drug Conjugates Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antibody drug Conjugates Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 ImmunoGen
9.1.1 ImmunoGen Antibody drug Conjugates Basic Information
9.1.2 ImmunoGen Antibody drug Conjugates Product Overview
9.1.3 ImmunoGen Antibody drug Conjugates Product Market Performance
9.1.4 ImmunoGen Business Overview
9.1.5 ImmunoGen Antibody drug Conjugates SWOT Analysis
9.1.6 ImmunoGen Recent Developments
9.2 Seattle Genetics
9.2.1 Seattle Genetics Antibody drug Conjugates Basic Information
9.2.2 Seattle Genetics Antibody drug Conjugates Product Overview
9.2.3 Seattle Genetics Antibody drug Conjugates Product Market Performance
9.2.4 Seattle Genetics Business Overview
9.2.5 Seattle Genetics Antibody drug Conjugates SWOT Analysis
9.2.6 Seattle Genetics Recent Developments
9.3 Roche
9.3.1 Roche Antibody drug Conjugates Basic Information
9.3.2 Roche Antibody drug Conjugates Product Overview
9.3.3 Roche Antibody drug Conjugates Product Market Performance
9.3.4 Roche Business Overview
9.3.5 Roche Antibody drug Conjugates SWOT Analysis
9.3.6 Roche Recent Developments
9.4 Takeda
9.4.1 Takeda Antibody drug Conjugates Basic Information
9.4.2 Takeda Antibody drug Conjugates Product Overview
9.4.3 Takeda Antibody drug Conjugates Product Market Performance
9.4.4 Takeda Business Overview
9.4.5 Takeda Antibody drug Conjugates SWOT Analysis
9.4.6 Takeda Recent Developments
10 Antibody drug Conjugates Market Forecast by Region
10.1 Global Antibody drug Conjugates Market Size Forecast
10.2 Global Antibody drug Conjugates Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antibody drug Conjugates Market Size Forecast by Country
10.2.3 Asia Pacific Antibody drug Conjugates Market Size Forecast by Region
10.2.4 South America Antibody drug Conjugates Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antibody drug Conjugates by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Antibody drug Conjugates Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Antibody drug Conjugates by Type (2024-2029)
11.1.2 Global Antibody drug Conjugates Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Antibody drug Conjugates by Type (2024-2029)
11.2 Global Antibody drug Conjugates Market Forecast by Application (2024-2029)
11.2.1 Global Antibody drug Conjugates Sales (K MT) Forecast by Application
11.2.2 Global Antibody drug Conjugates Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings